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Abstract:  Chalcones exhibit chemopreventive and antitumor effects. Tumor necrosis 
factor-related apoptosis-inducing ligand (TRAIL) is a naturally occurring anticancer agent 
that induces apoptosis in cancer cells and is not toxic to normal cells. We examined the 
cytotoxic and apoptotic effect of five chalcones in combination with TRAIL on prostate 
cancer cells. The cytotoxicity was evaluated by the MTT and LDH assays. The apoptosis 
was determined using flow cytometry with annexin V-FITC. Our study showed that all five 
tested chalcones: chalcone, licochalcone-A, isobavachalcone, xanthohumol, butein 
markedly augmented TRAIL-mediated apoptosis and cytotoxicity in prostate cancer cells 
and confirmed the significant role of chalcones in chemoprevention of prostate cancer.  
Keywords: chalcones; TRAIL (tumor necrosis factor-related apoptosis-inducing ligand); 
apoptosis; chemoprevention; prostate cancer 
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1. Introduction  
Chalcones (1,3-diphenyl-2-propen-1-ones)―one of the major classes of natural products with 
widespread distribution in spices, tea, beer, fruits and vegetables―have been recently subject of great 
interest for their pharmacological activities [1]. Chalcones are precursor compounds in flavonoid 
biosynthesis in plants. Chemically they consist of open-chain flavonoids in which the two aromatic 
rings are joined by a three-carbon α,β-unsaturated carbonyl system [2–4]. Chalcones have been 
reported to possess antiinflammatory, antimicrobial, antioxidant and anticancer properties [4–9].  
Prostate cancer is one of the most commonly diagnosed cancers in men, and the second leading 
cause of cancer deaths in the European Union and United States of America [10]. Many antitumor 
drugs have been developed for prostate cancer patients, but their intolerable systemic toxicity often 
limits their clinical use. Chemoprevention is one of the most promising approaches in prostate cancer 
research, in which natural or synthetic agents are used to prevent this malignant disease [10–12]. The 
in vitro studies showed that chalcones inhibit the proliferation of prostate cancer cells by inducing 
apoptosis and blocking cell cycle progression [13–17].  
Tumor necrosis factor related apoptosis inducing ligand (TRAIL), a member of TNF superfamily, 
selectively induces apoptosis in cancer cells with no toxicity against normal tissues. Soluble or 
expressed on lymphocytes T, macrophages and NK cells, molecules TRAIL plays an important role in 
immune surveillance and defense mechanisms against tumor cells. TRAIL induces programmed death 
in various cancer cells through its interaction with the death receptor TRAIL-R1 and/or   
TRAIL-R2 [18,19]. However, some tumor cells are resistant to TRAIL-mediated cytotoxicity. The 
decreased expression of death receptors TRAIL-R1 (DR4) and TRAIL-R2 (DR5) or increased 
expression of antiapoptotic proteins in cancer cells are involved in TRAIL-resistance [20]. We and 
others have shown that TRAIL-resistant prostate cancer cells can be sensitized by chemotherapeutic 
agents, ionizing radiation or dietary polyphenols [21–25]. 
In this work we investigated the apoptotic and/or cytotoxic effect of chalcones in combination with 
TRAIL on prostate cancer cells. Our results indicated that all five tested chalcones: chalcone, 
licochalcone-A, isobavachalcone, xanthohumol and butein markedly augment TRAIL mediated 
apoptosis in LNCaP prostate cancer cells. We showed for the first time that chalcones sensitize 
prostate cancer cells to TRAIL induced apoptosis. The TRAIL-mediated cytotoxic and apoptotic 
pathways may be a target of chemopreventive agents in prostate cancer cells and overcoming   
TRAIL-resistance by chalcones may be one of the mechanisms responsible for their cancer   
preventive effects. 
2. Results and Discussion  
2.1. Cytotoxic and Apoptotic Effects of Chalcones in Prostate Cancer Cells 
Recent epidemiological studies have confirmed the role of polyphenols in prevention of prostate  
cancer [11,26,27]. Chalcones are plant-derived polyphenols belonging to the flavonoid family and 
widely investigated in various therapeutic areas. The previous experimental studies suggested that 
these compounds exert in vitro chemopreventive activity [6–9]. Chalcones inhibit cell growth and 
induce apoptosis in prostate cancer cells [13–17]. Panduratin A, a chalcone isolated from Kaempferia Int. J. Mol. Sci. 2010, 11                 
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pandurata, induces apoptosis and G2/M cell cycle arrest in androgen-independent prostate cancer cells 
PC3 and DU145 [14]. Licochalcone A and isoliquiritigenin detected in Glycyrrhiza glabra inhibit 
proliferation and block cell cycle progression in the G2/M phase in PC3 and DU145 cells [15,16]. 
Xanthohumol identified in Humulus lupulus exhibited antiproliferative activities on PC3 and DU145 
cells [17]. We have demonstrated that treatment of LNCaP prostate cancer cells with chalcones inhibits 
cell proliferation by induced cytotoxicity and apoptosis. Figure 1 presents the structures of chalcones 
used in this study. 
Figure 1. Chemical structures of the studied chalcones. 
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The LNCaP cells were incubated for 48 hours with five chalcones: chalcone, licochalcone-A, 
isobavachalcone, xanthohumol and butein. The chalcones inhibited growth and induced apoptosis in 
prostate cancer cells in a dose dependent manner. The cytotoxic effect of chalcones at the 
concentrations of 20–50 μM on LNCaP cells were 1.80 ± 0.82%–9.19 ± 0.87% cell death (Figure 2A). 
The annexin V assay revealed apoptotic cells exposed to chalcones which is demonstrated in Figure 2B 
(statistical analysis in Table 1). These compounds induced 3.03  ±  0.19%–12.87  ±  0.20% apoptotic 
cells. Our study showed that all tested chalcones exhibited low cytotoxic and apoptotic activity against 
LNCaP cells. 
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Figure 2. Cytotoxic and apoptotic effects of chalcones on LNCaP prostate cancer cells. 
The cancer cells were incubated for 48 hours with five chalcones: chalcone, licochalcone-A, 
isobavachalcone, xanthohumol and butein at the concentrations of 20 μM and 50 μM. The 
values represent mean ± SD of three independent experiments performed in quadruplicate 
(n = 12) for cytototoxicity, or in duplicate (n = 6) for apoptosis (p < 0.05). (A) Cytotoxic 
activity of chalcones in LNCaP cells. The percentage of cell death was measured by MTT 
cytotoxicity assay. (B) Chalcone-induced apoptosis in LNCaP cells. Detection of apoptotic 
cell death by annexin V-FITC staining using flow cytometry.  
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Table 1. Apoptosis induced by chalcones - p values. 
 
2.2. Cytotoxic and Apoptotic Effects of TRAIL in Prostate Cancer Cells 
TRAIL is a naturally occurring anticancer agent expressed in immune cells that preferentially 
induces apoptosis in cancer cells [18,19]. Apoptosis is a highly regulated mechanism by which cells 
undergo programmed cell death. Resistance to apoptosis is a hallmark of cancer, with both loss of 
proapoptotic signals (decreased expression of death receptors TRAIL-R1 and TRAIL-R2) and the gain 
of the antiapoptotic mechanisms (increased expression of antiapoptotic proteins) contributing to 
tumorigenesis [19,20]. TRAIL induces programmed death in various cancer cells in vitro and  
in vivo [19,28]. We and others have shown that LNCaP prostate cancer cells are resistant to   
TRAIL-mediated cytotoxicity [23–25]. TRAIL induced cytotoxic and apoptotic effects in LNCaP cells 
in a dose-dependent manner. The cytotoxicity of TRAIL at the concentrations of 20–200 ng/mL after 
48 hours’ incubation were 7.27 ± 0.64%–23.91 ± 0.70% cell death (Figure 3A). Figure 3B presents 
TRAIL induced apoptosis in LNCaP cancer cells determined by annexin V staining followed by flow 
Post-hoc test
p= (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)
Control: LNCaP cells (1) 2E-05 1E-05 8E-06 1E-05 2E-05 3E-05 3E-05 2E-05 1E-05 2E-05
Chalcone 20 [µM] (2) 2E-05 2E-05 2E-05 8E-06 8E-06 2E-05 9E-06 3E-05 2E-05 3E-05
Chalcone 50 [µM] (3) 1E-05 2E-05 3E-05 2E-05 1E-05 8E-06 2E-05 2E-05 9E-06 9E-06
Licochalcone-A 20 [µM] (4) 8E-06 2E-05 3E-05 2E-05 0.1632 2E-05 8E-06 1E-05 3E-05 1E-05
Licochalcone-A 50 [µM] (5) 1E-05 8E-06 2E-05 2E-05 3E-05 0.8617 2E-05 2E-05 0.5419 8E-06
Isobavachalcone 20 [µM] (6) 2E-05 8E-06 1E-05 0.1632 3E-05 2E-05 2E-05 1E-05 3E-05 1E-05
Isobavachalcone 50 [µM] (7) 3E-05 2E-05 8E-06 2E-05 0.8617 2E-05 9E-06 2E-05 0.7127 2E-05
Xanthohumol 20 [µM] (8) 3E-05 9E-06 2E-05 8E-06 2E-05 2E-05 9E-06 3E-05 8E-06 2E-05
Xanthohumol 50 [µM] (9) 2E-05 3E-05 2E-05 1E-05 2E-05 1E-05 2E-05 3E-05 8E-06 9E-06
Butein 20 [µM] (10) 1E-05 2E-05 9E-06 3E-05 0.5419 3E-05 0.7127 8E-06 8E-06 2E-05
Butein 50 [µM] (11) 2E-05 3E-05 9E-06 1E-05 8E-06 1E-05 2E-05 2E-05 9E-06 2E-05Int. J. Mol. Sci. 2010, 11                 
 
 
5
cytometry. The 48 hours’ exposure to TRAIL increased the percentage of apoptotic cells in a   
dose-dependent manner to 7.50 ± 0.47%–25.23 ± 0.46%.  
Figure 3. Cytotoxic and apoptotic effect of TRAIL on LNCaP prostate cancer cells. The 
cancer cells were incubated for 48 hours with TRAIL at the concentrations of   
20–200 ng/mL. The values represent mean ± SD of three independent experiments 
performed in quadruplicate (n = 12) for cytototoxicity, or in duplicate (n = 6) for apoptosis 
(p < 0.05). (A) Cytotoxic activity of TRAIL in LNCaP cells. The percentage of cell death 
was measured by MTT cytotoxicity assay. (B) TRAIL-induced apoptosis in LNCaP cells. 
Detection of apoptotic cell death by annexin V-FITC staining using flow cytometry. 
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2.3. Cytotoxic and Apoptotic Effects of TRAIL in Combination with Chalcones in Prostate Cancer Cells 
One of the most challenging tasks concerning cancer is to induce apoptosis in malignant cells, 
researchers are increasingly focusing on natural products to modulate apoptotic signaling pathways 
[12,27,29,30]. The role of dietary flavonoids in prevention of prostate cancer has been confirmed in 
previous epidemiological studies, however the mechanism of chemoprevention by these polyphenols 
largely remains unknown [11]. Chalcones constitute an important group of flavonoids which besides 
antitumor activity possess immunomodulatory properties. There is accumulating evidence that cancer 
prevention by flavonoids affect the anticancer immunity [27,29]. Ferguson and Philpott reported about 
dietary bioactive food components interacting with the immune response and having potential to 
reduce the risk of cancer [31]. Jakobisiak et al. confirmed the role of TRAIL in the immune 
mechanisms of protection against cancer [32]. Immunomodulation through natural substances may be 
considered as an alternative for prevention of malignant disease [29,31]. 
As shown in Figures 2 and 3, chalcones or TRAIL alone induced little apoptotic and cytotoxic 
effect on LNCaP cells. We then tested chalcones in combination with TRAIL on prostate cancer cells. 
We investigated the cytotoxic effect on LNCaP cells of five chalcones: chalcone, licochalcone-A, 
isobavachalcone, xanthohumol and butein, at concentrations of 20 and 50 μM in combination with 
TRAIL at  concentrations of 20–100 ng/mL. The cytotoxicity measured by a MTT assay is shown in 
Figure 4. Chalcones in combination with TRAIL increased the percentage of cell death 
(22.98 ± 0.84%–80.06 ± 0.87%  for  chalcone,  25.36 ± 0.98%–89.32 ± 0.47%  for  licochalcone-A, 
24.47 ± 0.84%–85.90 ± 0.91% for isobavachalcone, 26.22 ± 1.22%–93.20 ± 0.60% for xanthohumol 
and 36.82 ± 0.87%–81.97 ± 0.84% for butein) compared to cytotoxicity of TRAIL and chalcones alone.  Int. J. Mol. Sci. 2010, 11                 
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Figure 4. Cytotoxic activity of TRAIL in combination with chalcones in LNCaP prostate 
cancer cells. The cancer cells were incubated for 48 hours with TRAIL at the 
concentrations of 20–100 ng/mL and chalcones: (A) chalcone, (B) licochalcone-A, (C) 
isobavachalcone, (D) xanthohumol and (E) butein at the at the concentrations of 20 μM and 
50 μM. The percentage of cell death was measured by MTT cytotoxicity assay. The values 
represent mean ± SD of three independent experiments performed in quadruplicate (n = 12) 
(p < 0.05).  
 
0
20
40
60
80
100
0 1 02 03 04 05 0
Chalcone [µM]
C
y
t
o
t
o
x
i
c
i
t
y
 
[
%
]
TRAIL-0 ng/ml
TRAIL-20 ng/ml
TRAIL-50 ng/ml
TRAIL-100 ng/ml
0
20
40
60
80
100
0 1 02 03 04 05 0
Licochalcone A [µM]
C
y
t
o
t
o
x
i
c
i
t
y
 
[
%
]
TRAIL-0 ng/ml
TRAIL-20 ng/ml
TRAIL-50 ng/ml
TRAIL-100 ng/ml
0
20
40
60
80
100
0 1 02 03 04 05 0
Isobavachalcone [µM]
C
y
t
o
t
o
x
i
c
i
t
y
 
[
%
]
TRAIL-0 ng/ml
TRAIL-20 ng/ml
TRAIL-50 ng/ml
TRAIL-100 ng/ml
0
20
40
60
80
100
0 1 02 03 04 05 0
Xanthohumol [µM]
C
y
t
o
t
o
x
i
c
i
t
y
 
[
%
]
TRAIL-0 ng/ml
TRAIL-20 ng/ml
TRAIL-50 ng/ml
TRAIL-100 ng/ml
0
20
40
60
80
100
0 1 02 03 04 05 0
Butein [µM]
C
y
t
o
t
o
x
i
c
i
t
y
 
[
%
]
TRAIL-0 ng/ml
TRAIL-20 ng/ml
TRAIL-50 ng/ml
TRAIL-100 ng/ml
 
 
B
C D
A
E
 
TRAIL and tested chalcones induced their cytotoxic effect in cancer cells by the apoptotic pathway, 
as the necrotic cell death percentage of LNCaP cells examined by Apoptest-FITC and lactate 
dehydrogenase assay was near 0%. 
We found out that chalcones strongly cooperated with TRAIL to induce apoptosis in LNCaP cells. 
The percentage of the apoptotic cells after 48 hours’ exposure to 100 ng/mL TRAIL and 50 μM 
chalcones were elevated at 82.71  ±  0.56% for chalcone, at 91.12  ±  1.04% for licochalcone-A, at 
86.83  ±  0.85% for isobavachalcone, at 92.53  ±  0.62% for xanthohumol and at 83.53  ±  0.64% for 
butein (Figure 5). Statistical analysis is demonstrated in Table 2. 
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Figure 5. TRAIL induced apoptosis in combination with chalcones in LNCaP prostate 
cancer cells. The cancer cells were incubated for 48 hours with TRAIL at the 
concentrations of 50 ng/ml and 100 ng/mL and chalcones: (A) chalcone, (B) licochalcone-A, 
(C) isobavachalcone, (D) xanthohumol and (E) butein at the concentrations of 20 μM and 
50  μM. Detection of apoptotic cell death by annexin V-FITC staining using flow 
cytometry. The values represent mean ± SD of three independent experiments performed in 
duplicate (n = 6) (p < 0.05). 
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Chalcones enhanced the apoptosis-inducing potential of TRAIL and sensitized TRAIL-resistant 
LNCaP prostate cancer cells. Two similar studies with chalcones showed that isoliquiritigenin and 
butein synergistically induced apoptosis with TRAIL in malignant tumor cells [33,34]. Yoshida et al. 
indicated that isoliquiritigenin overcomes TRAIL-resistance in HT29 human colon cancer cells 
through upregulation of death receptor TRAIL-R2 (DR5) [33]. Kim explained the molecular 
mechanism by which butein augments TRAIL-mediated apoptosis in U937 human leukemia cells and 
confirmed the ability of butein to increase expression of death receptor TRAIL-R2 (DR5) and the 
caspase-3 activation [34]. Except butein there is no evidence of TRAIL cotreatment with other tested 
chalcones. The cytotoxic and apoptotic effects of chalcone, licochalcone-A, isobavachalcone and Int. J. Mol. Sci. 2010, 11                 
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xanthohumol in combination with TRAIL on cancer cells were examined for the first time in our study. 
Therefore, further investigations will be required to explain the cellular signaling pathways by which 
chalcones sensitize cancer cells to TRAIL induced death. 
Table 2. Apoptosis induced by chalcones at concentrations 20 μM and 50 μM with TRAIL 
at concentrations 50 ng/mL and 100 ng/mL–p values. 
 
TRAIL - 100 ng/ml
Chalcones 20 µM Chalcones 50 µM
p = ( 1 )( 2 )( 3 )( 4 )( 5 )( 1 )( 2 )( 3 )( 4 )( 5 )
Chalcone (1) 0.402463 0.00012 0.000161 0.000112 0.000161 0.00012 0.000129 0.010564
Licochalcone (2) 0.402463 0.000161 0.000129 0.00012 0.000161 0.000112 0.000138 0.00012
Isobavachalcone (3) 0.00012 0.000161 0.00315 0.019365 0.00012 0.000112 0.00012 0.000112
Xanthohumol (4) 0.000161 0.000129 0.00315 0.000122 0.000129 0.000138 0.00012 0.000161
Butein (5) 0.000112 0.00012 0.019365 0.000122 0.010564 0.00012 0.000112 0.000161  
 
Our results demonstrated that chalcones markedly augmented TRAIL mediated apoptosis in 
prostate cancer cells. Chalcones restored TRAIL sensitivity in TRAIL-resistant LNCaP cells. In our 
study all five tested chalcones: chalcone, licochalcone-A, isobavachalcone, xanthohumol and butein 
exhibited strong cytotoxic and apoptotic effects in combination with TRAIL against prostate   
cancer cells.  
The different activity of chalcones in this study depends on the nature and position of substituents in 
the chalcone structure. The studied compounds with substituents in combination with TRAIL increased 
cytotoxic effect and apoptosis in comparison to chalcone. The presence of the methoxy group in 
xanthohumol at the 6’ position increases its activity compared to isobavachalcone. Xanthohumol alone 
and in combination with TRAIL was the most active compound in apoptosis induction of cancer cells 
(Tables 1 and 2). The isomerization of chalcones can convert their structures to flavanones. Our 
unpublished observations confirmed that isoxanthohumol, as an isomerization product of 
xanthohumol, showed with or without TRAIL lower cytotoxic and apoptotic effect against LNCaP 
cells than chalcone (without substituents). It may indicate the important role of the basic structure of 
chalcone in cytotoxic and apoptotic reactions. 
Many plant and animal extract rich in phenols and polyphenols shown various biological activities 
including antioxidant, anticancer and immunomodulatory properties [35–38]. TRAIL is a key effector 
molecule expressed on immune cells responsible for surveillance against tumor development [32]. Our 
study showed the impact of chalcones on the anticancer immune defense through the interaction and 
modulation of the TRAIL-mediated apoptotic pathway in prostate cancer cells. The findings suggest 
that chalcones may exert a chemopreventive effect in cooperation with endogenous TRAIL in vivo. 
The TRAIL potential enhancement by chalcones suggests that these compounds can be used in 
prostate cancer chemoprevention. 
  
Post - hoc test.  TRAIL - 50 ng/ml
Chalcones 20 µM Chalcones 50 µM
p = ( 1 )( 2 )( 3 )( 4 )( 5 )( 1 )( 2 )( 3 )( 4 )( 5 )
Chalcone (1) 0.000112 0.000161 0.000129 0.00012 0.000161 0.00012 0.000129 0.000112
Licochalcone (2) 0.000112 0.00012 0.000161 0.000112 0.000161 0.000112 0.000112 0.00012
Isobavachalcone (3) 0.000161 0.00012 0.000126 0.000257 0.00012 0.000112 0.00012 0.000112
Xanthohumol (4) 0.000129 0.000161 0.000126 0.00012 0.000129 0.000112 0.00012 0.000161
Butein (5) 0.00012 0.000112 0.000257 0.00012 0.000112 0.00012 0.000112 0.000161Int. J. Mol. Sci. 2010, 11                 
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3. Experimental Section  
3.1. Chemicals 
3.1.1. Chalcones 
The five chalcones: chalcone (trans-benzylideneacetophenone) (1), licochalcone-A (E-3-[5-(1,1-
diethyl-2-propenyl)-4-hydroxy-2-methoxyphenyl]-1-(4-hydroxypenyl)-2-propen-1-one) (2), isobava--
chalcone (2’,4’,4-trihydroxy-3’-[3’-methylbut-3’-ethyl]chalcone) (3), xanthohumol (2’,4,4’-tri-
hydroxy-3’-prenyl-6’-methoxychalcone) (4) and butein (2’,3,4,4’-tetrahydroxychalcone) (5)  were 
purchased from Alexis Biochemicals (Lausanne, Switzerland).  
3.1.2. TRAIL 
Recombinat human TRAIL was purchased from PeproTech Inc. (Rocky Hill, NJ, USA). 
3.2. Cell Culture 
The experiments were performed on human hormone-sensitivity prostate cancer LNCaP cells 
(DSMZ - German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany). The 
cancer cells were grown in monolayer cultures in RPMI 1640 medium with 10% fetal bovine serum,  
4 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin and incubated at 37 °C in 
atmosphere containing 5% CO2 [24,25]. Reagents for cells culture were purchased from PAA The Cell 
Culture Company (Pasching, Austria). 
3.3. Cytotoxicity Assay 
The cytotoxicity was measured by a 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium (MTT) 
assay as described [24,25,28]. The LNCaP cells (2  ×  10
5/mL) were seeded 48 hours before the 
experiments in a 96-well plate. Various combinations of chalcones (20 μM and 50 μM) with or without 
TRAIL (20–200 ng/mL) were added to the cells, and 48 hours later the medium was removed and  
20 μL MTT solutions (5 mg/mL) (Sigma Chemical Company, St Louis, MO, USA) were added to each 
well for 4 h. The resulting crystals were dissolved in DMSO. Controls included native cells and 
medium alone. The spectrophotometric absorbance of each well was measured using a microplate 
reader (ELx 800, Bio-Tek Instruments Inc., Winooski, VT, USA) at 550 nm. The percent cytotoxicity 
was calculated by the formula: percent cytotoxicity (cell death) = (1 − [absorbance of experimental 
wells/absorbance of control wells]) × 100%. 
3.4. Lactate Dehydrogenase Release Assay 
Lactate dehydrogenase (LDH) is a stable cytosolic enzyme that is released upon membrane damage 
in necrotic cells. LDH activity was measured using a commercial cytotoxicity assay kit (Roche 
Diagnostics GmbH, Mannheim, Germany), in which LDH released in culture supernatants is measured 
with a coupled enzymatic assay, resulting in conversion of a tetrazolium salt into red formazan 
product. The LNCaP cells were treated with various concentrations of chalcones (20 μM and 50 μM) Int. J. Mol. Sci. 2010, 11                 
 
 
10
alone and in combination with TRAIL (20–200 ng/mL) for the indicated period of time. The sample 
solution (supernatant) was removed and LDH released from cells was measured in culture medium. 
The maximal release was obtained after treating control cells with 1% Triton X-100 (Sigma Chemical 
Company, St. Louis, MO) for 10 minutes at a room temperature [24,25,28]. The necrotic percentage 
was expressed using the formula, (sample value/maximal release) × 100%. 
3.5. Determination of Apoptotic Cell Death by Annexin V-FITC Staining 
Apoptosis was measured using flow cytometry to quantify the levels of decentable 
phosphatidylserine (PS) on the outer membrane of apoptotic cells. Externalized PS on the outer surface 
of the cytoplasmic membrane becomes labeled by fluorescein labeled annexin V, which has a high 
affinity for PS-containing phospholipids bilayers. Prostate cancer cell line LNCaP (2 × 10
5/mL) cells 
were seeded in 24-well plates for 48 hours and then exposed to chalcones (20 μM and 50 μM) and/or 
TRAIL (20–200 ng/mL) for 48 hours. After a 48 hour incubation cancer cells were washed twice with 
PBS and resuspended in 1 mL of binding buffer. Five hundred microliters of cell suspension was then 
incubated with 5 μL of annexin V-FITC and 10 μL of propidium iodide (PI) for 10 min at a room 
temperature in the dark. Annexin V assay was performed using the Apoptotest-FITC Kit (Dako, 
Glostrup, Denmark). The population of annexin V-positive cells was evaluated by flow cytometry (BD 
FACScan, Becton Dickinson Immnunocytometry Systems, San Jose, CA, USA) [25,35]. 
3.6. Statistical Analysis 
The results are expressed as means ± S.D. obtained from three separate experiments performed in 
quadruplicates (n = 12) for cytototoxicity or duplicates (n = 6) for apoptosis. The experimental means 
were compared to the means of untreated prostate cancer cells harvested in a parallel manner and the 
data was polled for replicate experiments. Statistical significance was evaluated using one- and 
multiple-way ANOVA or Kruskal-Wallis test followed by the post hoc test. p-values < 0.05 were 
considered significant. 
4. Conclusions  
In this work we investigated the apoptotic and/or cytotoxic effect of five chalcones (chalcone, 
lipochalcone-A, isobavachalcone, xanthohumol and butein) on prostate cancer cells in combination 
with TRAIL. Our findings indicated that all tested chalcones: chalcone, lipochalcone-A, 
isobavachalcone, xanthohumol and butein markedly augment TRAIL mediated apoptosis in LNCaP 
cells. We showed for the first time that chalcones sensitize prostate cancer cells to TRAIL induced 
apoptosis. The obtained results suggest that chalcones help anticancer immune defense in which 
endogenous TRAIL takes part. The TRAIL-mediated cytotoxic and apoptotic pathways may be a 
target of the chemopreventive agents in prostate cancer cells and the overcoming TRAIL-resistance by 
chalcones may be one of the mechanisms responsible for their cancer preventive effects. Int. J. Mol. Sci. 2010, 11                 
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